Your browser doesn't support javascript.
loading
Complete Remission of Acute Myeloid Leukemia following Cisplatin Based Concurrent Therapy with Radiation for Squamous Cell Laryngeal Cancer.
Mody, Mayur D; Gill, Harpaul S; Higgins, Kristin A; Saba, Nabil F; Kota, Vamsi K.
Afiliação
  • Mody MD; Department of Internal Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Gill HS; Department of Internal Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Higgins KA; Department of Radiation Oncology, Emory University, Atlanta, GA 30322, USA; Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA.
  • Saba NF; Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA.
  • Kota VK; Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA.
Case Rep Hematol ; 2016: 8581421, 2016.
Article em En | MEDLINE | ID: mdl-27127664
Acute myeloid leukemia (AML) is a myeloid disorder with several established treatment regimens depending on patient and leukemic factors. Cisplatin is known to have strong leukemogenic potential and is rarely used even as salvage therapy in relapsed or refractory AML. We present a patient simultaneously diagnosed with AML and squamous cell carcinoma of the larynx, who was found to be in complete remission from AML following treatment with cisplatin based chemoradiotherapy for his laryngeal cancer.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article